Related Experiment Videos
Lung function after bilateral lower lobe lung volume reduction surgery for alpha1-antitrypsin emphysema
A F Gelb1, R J McKenna, M Brenner
1Dept of Medicine, Lakewood Regional Medical Center, School of Medicine, University of California, Los Angeles, USA.
The European Respiratory Journal
|November 26, 1999
Summary
Lung volume reduction surgery (LVRS) improves breathing in alpha1-antitrypsin emphysema patients by increasing lung elastic recoil, offering modest benefits for 2-3 years.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Genetics
Background:
- Emphysema in alpha1-antitrypsin deficiency causes airflow limitation.
- Lung volume reduction surgery (LVRS) is a treatment option for severe emphysema.
- Understanding the mechanisms of airflow limitation post-LVRS is crucial.
Purpose of the Study:
- To investigate the mechanism of airflow limitation after LVRS in alpha1-antitrypsin deficiency-related emphysema.
- To assess the physiological changes and clinical outcomes following bilateral LVRS.
Main Methods:
- Bilateral targeted lower lobe stapled LVRS via video thoracoscopy in six patients with alpha1-antitrypsin emphysema.
- Pulmonary function tests including FEV1, TLC, DLCO, and VC were measured pre- and post-surgery.
- Static lung elastic recoil and flow/pressure curves were analyzed.
Main Results:
- Four patients experienced dyspnea relief and improved walk tolerance 22-36 months post-LVRS.
- Forced expiratory volume in one second (FEV1) showed minimal improvement (30% to 33% predicted).
- Total lung capacity decreased, while diffusing capacity and vital capacity increased.
- Static lung elastic recoil at TLC increased, primarily accounting for improved airflow limitation.
Conclusions:
- Bilateral LVRS offers modest physiological improvement for 2-3 years in alpha1-antitrypsin emphysema.
- The primary mechanism for improvement is the increase in lung elastic recoil post-surgery.
- LVRS can alleviate symptoms and enhance exercise tolerance in select patients.